SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India reports 30% rise in Q4 net profit

05 Feb 2016 Evaluate

Sanofi India has reported results for fourth quarter and full year ended December 31, 2015.

The company has reported 29.95% rise in its net profit after exceptional items at Rs 120.20 crore as compared to Rs 92.50 crore for the same quarter in the previous year. The company’s total income has increased by 10.25% to Rs 581.13 crore for the quarter under review from Rs 527.10 crore for the corresponding quarter of the previous year. 

For the full year, the company has reported 21.92% rise in its net profit after exceptional items at Rs 321.50 crore for FY15 as compared to Rs 263.70 crore in FY14. The company’s total income has increased by 9.93% to Rs 2244.50 crore for FY15 from Rs 2041.80 crore for the previous year. 

Sanofi India Share Price

3559.80 -0.20 (-0.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×